What Tulip Diagnostics does

Tulip Diagnostics (P) Ltd. is a privately held Indian in-vitro diagnostics (IVD) manufacturer established in 1988 and headquartered in Bambolim, Goa. Operating under the Tulip Group umbrella across nine divisions (Tulip Diagnostics, Orchid Biomedical Systems, Qualpro Diagnostics, Zephyr Biomedicals, Viola Diagnostic Systems, Microxpress, Coral Clinical Systems, BioShields, and the acquired Biosense Technologies), the company designs, manufactures, and markets a broad IVD product portfolio spanning blood banking reagents (Eryclone, Matrix gel cards), coagulation reagents, serology, rapid immunochromatographic tests (Paracheck, Falcivax, Dengucheck), ELISA kits (Qualisa brand), chemiluminescence assays (Electra brand), clinical chemistry kits, microbiology culture media and antibiotic discs, disinfectants, newborn screening assays, and veterinary diagnostics. In-house instrumentation capabilities include indigenously developed analyzers (Matrix Readmax, Hemostar, Gr8 Lab, Babysafe, RFID immunoturbidimetry platforms) housed across two engineering units in Goa.

Manufacturing is concentrated in Verna Industrial Estate, Goa across eight plants, supplemented by facilities in Pantnagar, Uttarakhand. All plants are ISO 13485:2016 certified with most products CE marked and two facilities WHO prequalified for malaria rapid diagnostic tests, supporting exports to 88 countries. The commercial model combines one-time product sales of reagents and kits, instrumentation hardware sales (semi-automated and automated analyzers), and OEM/contract manufacturing for international brands. Domestically, Tulip operates through 12 branch offices, a 350-distributor network, and 267+ sales/service professionals reaching 20,000+ customers including blood banks, hospital labs, microbiology labs, and point-of-care settings. Internationally, the company sells its own branded products, neutral-label products, and contract-manufactured reagents, with direct procurement relationships to WHO and UNICEF for global health programs. The 2020 acquisition of Biosense Technologies extended the company into portable point-of-care diagnostic devices aligned with Digital India and Make in India objectives.

Name

Tulip Diagnostics

Legal name

Tulip Diagnostics (P) Ltd.

Website

https://tulipgroup.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Tulip Diagnostics is a Goa-based Indian IVD manufacturer, founded 1988, producing diagnostic reagents, kits, and analyzers across blood banking, rapid tests, ELISA, chemiluminescence, clinical chemistry, microbiology, and disinfectants. It serves 20,000+ domestic customers via 12 branches and exports to 88 countries, with WHO and UNICEF procurement relationships.

Ownership category

akta.pro rank

Product category

In-vitro Diagnostics (IVD)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Hematology & Coagulation Diagnostics (HLAHAAAB), Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

Keywords

• In-vitro diagnostics
• Diagnostic reagents kits
• Clinical chemistry analyzers
• Blood banking reagents
• Microbiology culture media

Headquarters

HQ city

Bambolim

HQ country

India

HQ region

Asia

Offices24 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. IVD Reagents and Kits Manufacturing: Manufacturing and marketing of in-vitro diagnostic reagents and kits nationally and internationally including blood grouping, coagulation, serology, rapid tests, ELISA, and chemiluminescence products
2. Clinical Chemistry Products: Clinical chemistry kits, immunoassay reagents, semi-automated and automated analyzers
3. Microbiology Products: Dehydrated culture media, bases, supplements, microbiology stains, laboratory reagents and antibiotic sensitivity discs
4. Disinfectants and Antiseptics: High technology disinfectants and infection/contamination prevention products including hand disinfectants, antiseptics, surface disinfectants
5. OEM and Contract Manufacturing: Contract manufacturing services for international companies, OEM/neutral label products
6. Instrumentation: Marketing of immunoassay reagents, semi-automated and automated analyzers for the IVD Industry through Coral Clinical Systems

Go-to-market motion3 records

Distribution channels4 records

Marketing channels3 records

Core offering

Tulip Diagnostics manufactures and markets in-vitro diagnostic (IVD) reagents, kits, and instruments across multiple technology platforms including blood banking, coagulation, serology, rapid tests, ELISA, chemiluminescence, clinical chemistry, microbiology, and newborn screening. The company also produces disinfectants, antiseptics, dehydrated culture media, and antibiotic sensitivity discs, while offering semi-automated and automated analyzers for clinical laboratories and hospitals.

Product overview

Tulip Diagnostics (P) Ltd is a comprehensive in-vitro diagnostics company offering a broad portfolio of diagnostic products across multiple technology platforms. The company operates as a multi-divisional organization with specialized divisions including Tulip Diagnostics, Orchid Biomedical Systems, Qualpro Diagnostics, Zephyr Biomedicals, Viola Diagnostic Systems, Coral Clinical Systems, BioShields, Microxpress, and Biosense Technologies. The product portfolio spans Blood Banking (Eryclone, Matrix gel cards, Eryscreen reagents), Coagulation (Liquiplastin, Uniplastin, Celin-SE), Serology (Rhelax, Tydal), Rapid Tests (Paracheck, Falcivax, Dengucheck, Enterocheck), ELISA (Qualisa brand), Chemiluminescence (Electra brand), Clinical Chemistry, Microbiology, Disinfectants, Newborn Screening, and Veterinary Diagnostics. The company also offers a range of automated and semi-automated instrumentation including analyzers for matrix gel systems, coagulation, ELISA, CLIA, and clinical chemistry. Products are exported to approximately 88 countries with multiple WHO prequalified products and CE certified offerings.

Differentiator

Problem solved

Functional benefit

Brands

• Matrix: Gel card technology platform for blood banking including Matrix ABO/Rho(D) cards, AHG cards, and related instruments
• Eryclone
• Paracheck
• Falcivax
• Qualisa
• Electra
• Coral Clinical Systems
• Microxpress
• BioShields
• Turbosmart
• Tulip IBG (Instrument Business Group)
• Coral Instrumentation Division

Products and services

• Blood Banking Products Complete blood banking diagnostics including blood grouping reagents (Eryclone Anti-A, Anti-B, Anti-D), column agglutination technology (Matrix gel cards), rapid card tests, Coombs reagents, and Rh phenotyping reagents for transfusion medicine in hospitals and blood banks.
• Coagulation Products Coagulation reagents including PT reagents, aPTT reagents, thrombin time reagents, D-dimer reagents, LA reagents, control plasmas, and factor deficient plasmas for hemostasis testing in clinical laboratories.
• Serology Products Serological reagents including rheumatology (ASO, CRP, RF, SLE), febrile disease reagents (WIDAL antigens), Brucellosis reagents, Proteus reagents, infectious disease reagents, and turbidimetry reagents for diagnostic testing.
• Rapid Diagnostic Tests Point-of-care rapid immunochromatographic tests for malaria, dengue, HIV, HCV, HBsAg, syphilis, hepatitis, leptospirosis, typhoid, scrub typhus, rheumatology, pregnancy, drugs of abuse, cancer markers, and cardiac markers.
• ELISA Products Enzyme-linked immunosorbent assay products including HIV, HBsAg, HCV, Treponema, Malaria, Dengue, thyroid markers, fertility markers, autoimmune markers, vitamins, and TORCH panel under the Qualisa brand.
• Chemiluminescence Products Chemiluminescence immunoassay products under the Electra brand for HIV Ag/Ab, HBsAg, HCV, Tp.Ab, Malaria Ag, thyroid markers, fertility markers, autoimmune markers, anemia/allergy markers, cancer markers, diabetic markers, vitamins, and TORCH panel.
• Instrumentation/Analyzers Automated and semi-automated analyzers including Matrix Gel System, coagulation analyzers, turbidimetry-nephelometry analyzers, ELISA processors, chemiluminescence (CLIA) analyzers, RDT analyzers, hemoglobin monitoring devices, HbA1c monitoring devices, and clinical chemistry analyzers.
• Clinical Chemistry Products Clinical chemistry reagent kits, controls, immunoturbidimetry reagents, and chemistry analyzers for routine and specialized biochemical testing in clinical laboratories.
• Microbiology Products Dehydrated culture media, ready prepared plates, antimicrobial susceptibility discs, stains, indicators, analytical reagents, microbiology kits and instruments for microbiology laboratories.
• Disinfectants and Antiseptics Infection and contamination prevention products including hand disinfectants, antiseptics, surface disinfectants, instrument disinfectants, environment disinfectants, and disinfection equipment for healthcare facilities.
• Newborn Screening Products Newborn screening diagnostics including rapid tests, ELISAs (G6PD, TSH, 17-OHP, Biotinidase, MSUD, PKU, T-galactose), biochemical tests, BornSafe instruments, and Babysafe Analyzer for early detection of metabolic and genetic disorders.
• Veterinary Diagnostics Veterinary diagnostic products including clinical biochemistry reagents, clinical biochemistry analyzers, hematology analyzers, Brucellosis tests, and Mastitis tests for animal health diagnostics.
• POCT/Fluorescence Immunoassays Point-of-care fluorescence immunoassay tests for thyroid markers, fertility markers, autoimmune markers, diabetic markers, inflammation, anemia/allergy markers, coagulation, cardiac markers, vitamins, and allergy testing.
• Matrix Readmax (Matrix Card Reader) Automated card reader for Matrix gel cards used in blood banking diagnostics, enabling automated reading and analysis of column agglutination tests.
• Babysafe Analyzer Analyzer for newborn screening diagnostics to detect metabolic and genetic disorders including G6PD, TSH, 17-OHP, Biotinidase, MSUD, PKU, and T-galactose.
• RedSpot-PE Urinary Congo Red rapid diagnostic test for pre-eclampsia screening in pregnant women, designed for use in clinical and point-of-care settings.
• PyroCHECK Rapid immunochromatographic test for simultaneous detection of Malaria Pv/Pf antigen, IgM antibodies to S. typhi, and Dengue NS1 antigen as a multi-pathogen rapid diagnostic test.

Quantifiable outcome

• WHO Prequalified for Malaria Rapid tests - Two manufacturing units meet WHO quality standards
• +2 more outcomes

Named customers2 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered core.

• WHOcoreOthersWorld Health Organization purchases Tulip Diagnostics products directly for their various Health Programs globally. Two of Tulip's manufacturing units are WHO prequalified for Malaria Rapid tests, demonstrating the company's compliance with international quality standards.
• UNICEFcoreOthersUNICEF purchases Tulip Diagnostics products directly for various Health Programs worldwide as part of international public health initiatives.
• Biosense TechnologiescoreStrategic or Co-development PartnerAcquired Biosense Technologies India to expand Point-of-care testing (POCT) capabilities. Biosense was created by Medical professionals, Engineers, Product designers and IT coders to design portable yet affordable devices for basic healthcare screening, aligned with Digital India and Make in India campaigns. This acquisition supports long-term growth in emerging market diagnostics globally.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Siemens Healthineers: Broad medical-technology and IVD incumbent (Atellica/ADVIA Centaur systems, clinical chemistry, immunoassay). Competes for Indian hospital-lab automation contracts overlapping Tulip's clinical-chemistry and coagulation placements.
• Roche Diagnostics: Largest global IVD player with full-stack immunoassay, clinical chemistry, molecular and tissue diagnostics. Sets the technology ceiling that mid-tier players like Tulip must compete against in Indian tertiary hospitals.
• Bio-Rad Laboratories: US-headquartered life-science and clinical diagnostics major with broad IVD reagent, quality-control and blood-banking portfolios. Operates in the same lab segments as Tulip but at materially greater scale and R&D depth.
• Abbott Diagnostics: Global IVD incumbent covering immunoassay, clinical chemistry, hematology, molecular and rapid diagnostics across developed and emerging markets. Competes across Tulip's full reagent/instrument stack at the high end of hospital labs.

Direct peers

• SD Biosensor: Korean IVD company focused on rapid diagnostic tests (malaria, infectious disease) with strong WHO/UNICEF procurement presence. Directly competes with Tulip's Paracheck/Falcivax franchise in global public-health tenders.
• Trivitron Healthcare: Indian medical technology company spanning IVD reagents, instruments, newborn screening and clinical chemistry with an emerging-market export orientation — overlapping with Tulip's mid-tier portfolio and POCT/newborn-screening adjacencies.
• Transasia Bio-Medicals: Largest Indian IVD manufacturer with overlapping reagent, instrument and blood-banking portfolio serving Indian hospitals, labs and export markets. Closest competitor to Tulip domestically and across emerging-market tenders.
• Agappe Diagnostics: Indian IVD manufacturer of reagents, rapid tests and instruments with overlapping clinical chemistry, serology and hematology portfolios and pan-India distribution serving tier-2/3 labs.
• ERBA Mannheim (Transasia-Erba Group): Germany/India based mid-tier global IVD company with comparable clinical chemistry, hematology and immunoassay instruments/reagents and emerging-market footprint. Directly competes with Tulip in international tenders and shared distribution.

Emerging players

• ARKRAY Inc. Japan-based IVD manufacturer with strong diabetes/HbA1c and urinalysis franchises plus emerging clinical chemistry; comparable mid-tier international footprint targeting emerging markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tulip Diagnostics